Atlas FDA

Senographe Pristina 3D

FDA premarket approval P130020/S003 · decided 2017-12-28

Approval details

PMA number
P130020
Supplement
S003
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Senographe Pristina 3D
Generic name
Digital breast tomosynthesis
Applicant
GE Healthcare
Date received
2017-10-26
Decision date
2017-12-28
Days to decision
63 days
Decision code
APPR
Product code
OTE
Advisory committee
Radiology
Expedited review
No
Location
Waukesha, WI
Statement
Approval for a change to Senographe Pristina 3D to add a new Digital Breast Tomosynthesis (DBT) Automatic Optimization of Parameters (AOP) table, called 3D STD+. This new AOP table enables the acquisition of DBT datasets at a dose equivalent to 2D STD+, already enabled on Senographe Pristina for 2D examination. As in 2D, the user will be able to choose which AOP table to use for 3D acquisitions: 3D STD or 3D STD+.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
View (K253639)GE Healthcare2026-01-08
MR Contour DL (K242925)GE Healthcare2025-04-01
Digital Expert Access with Remote Scanning (K232346)GE Healthcare2023-10-27
Precision DL (K223212)GE Healthcare2023-04-27
Xeleris V Processing and Review System (K221680)GE Healthcare2023-03-01
Omni Legend (K221932)GE Healthcare2022-09-02
Voluson P6, Voluson P8 (K213689)GE Healthcare2022-02-17
Voluson S6, Voluson S8, Voluson S8t, Voluson S10, Voluson S10 Expert (K213642)GE Healthcare2022-01-13